Diabetes: Towards a coxsackievirus B-based vaccine to combat T1DM
暂无分享，去创建一个
[1] O. Laitinen,et al. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes , 2017, Diabetologia.
[2] D. Eizirik,et al. Viral infections in type 1 diabetes mellitus — why the β cells? , 2016, Nature Reviews Endocrinology.
[3] S. Tracy,et al. Enteroviruses, hygiene and type 1 diabetes: toward a preventive vaccine , 2015, Reviews in medical virology.
[4] N. Morgan,et al. Enteroviruses as causative agents in type 1 diabetes: loose ends or lost cause? , 2014, Trends in Endocrinology & Metabolism.
[5] N. Morgan,et al. Detection of a Low-Grade Enteroviral Infection in the Islets of Langerhans of Living Patients Newly Diagnosed With Type 1 Diabetes , 2014, Diabetes.
[6] M. Knip,et al. Developing a vaccine for Type 1 diabetes through targeting enteroviral infections , 2014, Expert review of vaccines.
[7] M. Craig,et al. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies , 2011, BMJ : British Medical Journal.
[8] D. Hober,et al. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host , 2010, Nature Reviews Endocrinology.
[9] N. Sarvetnick,et al. Target cell defense prevents the development of diabetes after viral infection , 2002, Nature Immunology.
[10] D. Hober,et al. Enteroviral pathogenesis of type 1 diabetes: queries and answers. , 2013, Current opinion in infectious diseases.